Colleran David bought ANIK
March 10, 2025 · Form 4 insider transaction
Colleran David bought 5,465 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,465
Price
$0.00
Total value
N/A
InsiderColleran David
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after39,590
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the second vesting installment of RSUs granted on March 9, 2023.; Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024.